Notably, the reactivation of melatonergic signaling by forced MT1 expression through treatment with the DNMT1 inhibitor 5-aza-2'-deoxycytidine suppressed the growth of oral squamous cell carcinoma lines (Nakamura et al., 2008[136]). Here, MTNR1A is linked to oral cavity squamous cell carcinoma.